InvestorsHub Logo
Followers 4
Posts 1195
Boards Moderated 0
Alias Born 10/03/2015

Re: jondoeuk post# 193

Wednesday, 05/04/2016 4:12:53 PM

Wednesday, May 04, 2016 4:12:53 PM

Post# of 977
Q: What will TRIL present at ASCO-2016?

At ASCO we will present “Trial in Progress category” it’s not data, but explaining what the trial is, it will be a poster presentation, entitled “ SIRPaFc, a CD47-Blocking Cancer Immunotherapeutic, Triggers Phagocytosis of Lymphoma Cells by Both Classically (M1) and Alternatively (M2) Activated Macrophages ”.